Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058550 · ClinicalTrials.gov registry record · Phase 1
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT02058550: Completed Phase 1 study, sponsored by Stanford University.
NCT02058550 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02058550, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This randomized, pilot phase I trial studies whether phone or email reminders increases vaginal dilator use in patients with endometrial, cervical, or vaginal cancers after they undergo brachytherapy. Brachytherapy is a type of internal radiation which uses radioactive material placed directly into or near a tumor to kill tumor cells. A reminder program may help increase use of vaginal dilators and decrease long-term side effects following brachytherapy.
Interventions
- OTHER survey administration
- BEHAVIORAL telephone-based intervention
- OTHER computer-assisted intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-10-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058550
The ClinicalTrials.gov registry entry for NCT02058550 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which survey administration is the first listed.
NCT02058550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058550 about?
NCT02058550 is a clinical study titled "Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy". This randomized, pilot phase I trial studies whether phone or email reminders increases vaginal dilator use in patients with endometrial, cervical, or vaginal cancers after they undergo brachytherapy. Brachytherapy is a type of internal radiation which uses radioactive material placed directly into ...
What is the current status of trial NCT02058550?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2014-09. Estimated completion is 2020-10-23.
What interventions are being tested in trial NCT02058550?
The interventions under investigation include: survey administration (OTHER), telephone-based intervention (BEHAVIORAL), computer-assisted intervention (OTHER).
Who is sponsoring clinical trial NCT02058550?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.